Recent advances in malaria drug discovery |
| |
| Authors: | Marco A Biamonte Jutta Wanner Karine G Le Roch |
| |
| Institution: | 1. Drug Discovery for Tropical Diseases, Suite 230, San Diego, CA 92121, USA;2. Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, Small Molecules Research, Discovery Chemistry, 340 Kingsland Street, Nutley, NJ 07110, USA;3. Institute for Integrative Genome Biology, Center for Disease Vector Research, Department of Cell Biology and Neuroscience, University of California at Riverside, CA 92521, USA |
| |
| Abstract: | This digest covers some of the most relevant progress in malaria drug discovery published between 2010 and 2012. There is an urgent need to develop new antimalarial drugs. Such drugs can target the blood stage of the disease to alleviate the symptoms, the liver stage to prevent relapses, and the transmission stage to protect other humans. The pipeline for the blood stage is becoming robust, but this should not be a source of complacency, as the current therapies set a high standard. Drug discovery efforts directed towards the liver and transmission stages are in their infancy but are receiving increasing attention as targeting these stages could be instrumental in eradicating malaria. |
| |
| Keywords: | Malaria Antimalarial Drugs Review |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
